(Q39421556)

11 September 2017

title

The inhibition of activated factor XII (Hageman factor) by antithrombin III: the effect of other plasma proteinase inhibitors (English)

2 references

11 September 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A65173

12 April 2022

The inhibition of activated factor XII (hageman factor) by antithrombin III: The effect of other plasma proteinase inhibitors (English)

1 reference

https://api.crossref.org/works/10.1016/0006-291X(77)91387-0

12 April 2022

1 reference

https://api.crossref.org/works/10.1016/0006-291X(77)91387-0

12 April 2022

0 references

1 reference

https://api.crossref.org/works/10.1016/0006-291X(77)91387-0

12 April 2022

author name string

J. Y. Chan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A65173

12 April 2022

C. E. Burrowes

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A65173

12 April 2022

F. M. Habal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A65173

12 April 2022

H. Z. Movat

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A65173

12 April 2022

language of work or name

English

0 references

publication date

1 January 1977

1 reference

11 September 2017

10 January 1977

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=65173

full work available at URL

12 April 2022

https://api.elsevier.com/content/article/PII:0006291X77913870?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-291X(77)91387-0

https://api.elsevier.com/content/article/PII:0006291X77913870?httpAccept=text/plain

12 April 2022

1 reference

https://api.crossref.org/works/10.1016/0006-291X(77)91387-0

Biochemical and Biophysical Research Communications

12 April 2022

published in

1 reference

11 September 2017

volume

74

1 reference

11 September 2017

issue

1

1 reference

11 September 2017

page(s)

150-158

1 reference

The inhibition of human plasma Kallikrein by antithrombin III

11 September 2017

cites work

3

7

175

Burrowes

1975

1 reference

https://api.crossref.org/works/10.1016/0006-291X(77)91387-0

Interaction between factor XII (Hageman factor), high molecular weight kininogen and prekallikrein

12 April 2022

8

9

Chan

1976

1 reference

https://api.crossref.org/works/10.1016/0006-291X(77)91387-0

Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation

12 April 2022

10

52

1402

Schreiber

1973

1 reference

https://api.crossref.org/works/10.1016/0006-291X(77)91387-0

Purification of factor XII (Hageman factor) from human plasma

12 April 2022

11

8

337

Chan

1976

1 reference

https://api.crossref.org/works/10.1016/0006-291X(77)91387-0

Isolation of two functionally different kininogens from human plasma--separation from proteinase inhibitors and interaction with plasma kallikrein

12 April 2022

12

23

2291

Habal

1974

1 reference

https://api.crossref.org/works/10.1016/0006-291X(77)91387-0

The purification of activated Hageman factor (activated factor XII)

12 April 2022

14

1

967

Ratnoff

1962

1 reference

https://api.crossref.org/works/10.1016/0006-291X(77)91387-0

Protein measurement with the Folin phenol reagent

12 April 2022

17

193

265

Lowry

1951

1 reference

https://api.crossref.org/works/10.1016/0006-291X(77)91387-0

Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein

12 April 2022

18

132

329

Harpel

1970

1 reference

https://api.crossref.org/works/10.1016/0006-291X(77)91387-0

Studies on the Antithrombin and Heparin Co-factor Activities of a Fraction Adsorbed from Plasma by Aluminum Hydroxide

12 April 2022

20

3

397

Monkhouse

1955

1 reference

https://api.crossref.org/works/10.1016/0006-291X(77)91387-0

Quantitative aspects of antithrombin and heparin in plasma

12 April 2022

21

184

627

Waugh

1956

1 reference

https://api.crossref.org/works/10.1016/0006-291X(77)91387-0

Blood coagulation and fibrinolysis

12 April 2022

24

10

85

Heimburger

1971

1 reference

https://api.crossref.org/works/10.1016/0006-291X(77)91387-0

Purification of canine antithrombin III-heparin cofactor using affinity chromatography

12 April 2022

26

61

1147

Damus

1974

1 reference

https://api.crossref.org/works/10.1016/0006-291X(77)91387-0

Inhibition of purified plasma Kallikrein by antithrombin III and heparin

12 April 2022

29

7

223

Vennerod

0 references

Antithrombin-heparin cofactor: an inhibitor of plasma kallikrein

30

175

737

Lahiri

1976

1 reference

https://api.crossref.org/works/10.1016/0006-291X(77)91387-0

Anticoagulant Action of Heparin

12 April 2022

31

246

355

Damus

1973

1 reference

https://api.crossref.org/works/10.1016/0006-291X(77)91387-0

Inhibition of bovine factor IXa and factor Xa.beta. by antithrombin III

12 April 2022

33

15

373

Kurachi

1976

1 reference

https://api.crossref.org/works/10.1016/0006-291X(77)91387-0

12 April 2022

Identifiers

1 reference

11 September 2017

1 reference